Can spiritual sessions ease the toll of leukemia treatment?
NCT ID NCT07405424
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looks at whether adding guided spiritual care sessions to standard hospital care is possible and helpful for adults newly diagnosed with acute leukemia. Seventy participants will be randomly assigned to receive either regular spiritual visits or usual care. The goal is to see if patients accept the sessions and if they report better spiritual well-being and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- guided spiritual care sessions
- What this could lead to
- If it works, this could show that adding spiritual care to standard treatment improves emotional well-being and quality of life for leukemia patients.
- What could go wrong
- This is a small, early feasibility study (70 participants) and does not test survival or cure. Results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UChicago Medicine Comprehensive Cancer Center
RECRUITINGChicago, Illinois, 60637, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Tumor's DNA guide better cancer care for kids?
- A guided path back to work after blood cancer: a trial tests the impact
- Can a new tracer light up cancer growth?
- Could a platelet-boosting drug shorten recovery after stem cell transplants?
- Can a different immune drug cut viral infections after stem cell transplants?